Aigen Investment Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-19,569
| Closed | -$172K | – | 1073 |
|
|
2023
Q4 | $172K | Buy |
+19,569
| New | +$172K | 0.03% | 685 |
|
|
2023
Q3 | – | Sell |
-53,988
| Closed | -$1.37M | – | 1131 |
|
|
2023
Q2 | $1.37M | Buy |
53,988
+42,150
| +356% | +$1.07M | 0.2% | 137 |
|
|
2023
Q1 | $381K | Sell |
11,838
-24,412
| -67% | -$786K | 0.05% | 366 |
|
|
2022
Q4 | $669K | Buy |
+36,250
| New | +$669K | 0.09% | 220 |
|
|
2021
Q3 | – | Sell |
-7,866
| Closed | -$233K | – | 691 |
|
|
2021
Q2 | $233K | Buy |
+7,866
| New | +$233K | 0.04% | 375 |
|
|
2020
Q4 | – | Sell |
-26,199
| Closed | -$659K | – | 1145 |
|
|
2020
Q3 | $659K | Buy |
26,199
+14,839
| +131% | +$373K | 0.08% | 350 |
|
|
2020
Q2 | $277K | Buy |
11,360
+3,442
| +43% | +$83.9K | 0.04% | 633 |
|
|
2020
Q1 | $117K | Sell |
7,918
-1,295
| -14% | -$19.1K | 0.02% | 833 |
|
|
2019
Q4 | $150K | Buy |
+9,213
| New | +$150K | 0.02% | 609 |
|